• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.36% Nasdaq Up0.45%

    AMAG Pharmaceuticals, Inc. (AMAG)

    -NasdaqGS
    69.35 Up 1.58(2.33%) 4:00PM EDT
    |After Hours : 69.35 0.00 (0.00%) 4:24PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 89,505   53,253   25,494   24,802  
    Cost of Revenue21,026  11,758  2,968  2,743  
    Gross Profit 68,479   41,495   22,526   22,059  
    Operating Expenses
    Research Development6,988  7,764  5,358  4,540  
    Selling General and Administrative32,112  25,604  12,875  16,284  
    Non Recurring571  11,501   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 28,808   (3,374) 4,293   1,235  
    Income from Continuing Operations
    Total Other Income/Expenses Net71  264  294  269  
    Earnings Before Interest And Taxes28,879  (3,110)4,587  1,504  
    Interest Expense10,367  7,041  3,129  3,051  
    Income Before Tax18,512  (10,151)1,458  (1,547)
    Income Tax Expense5,608  (153,159) -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops12,904  143,008  1,458  (1,547)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 12,904   143,008   1,458   (1,547)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 12,904   143,008   1,458   (1,547)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.